Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 26;13(4):204.
doi: 10.3390/jfb13040204.

Two-Dimensional Graphitic Carbon Nitride (g-C3N4) Nanosheets and Their Derivatives for Diagnosis and Detection Applications

Affiliations
Review

Two-Dimensional Graphitic Carbon Nitride (g-C3N4) Nanosheets and Their Derivatives for Diagnosis and Detection Applications

Mehrab Pourmadadi et al. J Funct Biomater. .

Abstract

The early diagnosis of certain fatal diseases is vital for preventing severe consequences and contributes to a more effective treatment. Despite numerous conventional methods to realize this goal, employing nanobiosensors is a novel approach that provides a fast and precise detection. Recently, nanomaterials have been widely applied as biosensors with distinctive features. Graphite phase carbon nitride (g-C3N4) is a two-dimensional (2D) carbon-based nanostructure that has received attention in biosensing. Biocompatibility, biodegradability, semiconductivity, high photoluminescence yield, low-cost synthesis, easy production process, antimicrobial activity, and high stability are prominent properties that have rendered g-C3N4 a promising candidate to be used in electrochemical, optical, and other kinds of biosensors. This review presents the g-C3N4 unique features, synthesis methods, and g-C3N4-based nanomaterials. In addition, recent relevant studies on using g-C3N4 in biosensors in regard to improving treatment pathways are reviewed.

Keywords: antimicrobial activity biomedical applications; biosensors; diagnosis; graphitic carbon nitride; nanomaterials.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
(A) Various g-C3N4 precursors and the corresponding temperatures for their thermal condensation into g-C3N4-, adapted from reference [50] under the terms and conditions of the Creative Commons Attribution (CC BY) license. (B) g-C3N4 structure, adapted from reference [51] under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Figure 2
Figure 2
Activation of g-C3N4 on glassy carbon electrode and the redox reaction on the developed electrochemical biosensor for serotonin (5-HT)-. Adapted from reference [86] under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Figure 3
Figure 3
Different schemes of fluorescent reagent-less protein-based biosensors. Single-fluorophore-based biosensors: Change in conformation (A) or target interaction (B) changes the environment of fluorophore. Two-fluorophore-based biosensors: In between two different fluorophores, FRET is recorded (fluorescent proteins) (C), or by breaking the stack of two fluorescent dyes which are identical (D). Modular design-based biosensors: a part in the merged system with the recognition element can interact with either the target bound (E) or the target-free state (F) so that when the target binds, the signal is transduced, Reproduced from Ref. [185] under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Figure 4
Figure 4
Differet categories of ECL systems. (A) Luminophore and co-reactant-involved reaction-based system; (B) co-reaction accelerator-involved reaction-mediated system; (C) resonance energy transfer (RET) reactions-incorporated system; and a (D) signal amplification method-incorporated system. Adapted from Ref. [209] under the terms and conditions of the Creative Commons Attribution (CC BY) license.

Similar articles

Cited by

References

    1. Srinivas P.R., Kramer B.S., Srivastava S. Trends in Biomarker Research for Cancer Detection. Lancet Oncol. 2001;2:698–704. doi: 10.1016/S1470-2045(01)00560-5. - DOI - PubMed
    1. Samadi A., Pourmadadi M., Yazdian F., Rashedi H., Navaei-Nigjeh M., Eufrasio-da-silva T. Ameliorating Quercetin Constraints in Cancer Therapy with PH-Responsive Agarose-Polyvinylpyrrolidone -Hydroxyapatite Nanocomposite Encapsulated in Double Nanoemulsion. Int. J. Biol. Macromol. 2021;182:11–25. doi: 10.1016/j.ijbiomac.2021.03.146. - DOI - PubMed
    1. Ludwig J.A., Weinstein J.N. Biomarkers in Cancer Staging, Prognosis and Treatment Selection. Nat. Rev. Cancer. 2005;5:845–856. doi: 10.1038/nrc1739. - DOI - PubMed
    1. Azimi S., Farahani A., Sereshti H. Plasma-functionalized highly aligned CNT-based biosensor for point of care determination of glucose in human blood plasma. Electroanalysis. 2020;32:394–403. doi: 10.1002/elan.201800895. - DOI
    1. Bohunicky B., Mousa S.A. Biosensors: The New Wave in Cancer Diagnosis. Nanotechnol. Sci. Appl. 2011;4:1–10. doi: 10.2147/NSA.S13465. - DOI - PMC - PubMed

LinkOut - more resources